Evidence map›Paper›PMID 26043038›Full record

ReviewNutrients2015

Effect of dietary Fatty acids on human lipoprotein metabolism: a comprehensive update.

Esther M M Ooi, Gerald F Watts, Theodore W K Ng, P Hugh R Barrett

Open access · goldAbstract readReview
In one paragraph

Review in Nutrients, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 1 pooled it
9.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 1 synthesis or guideline pooled it, 123 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Review
  8. Association of Plasma Omega-3 Fatty Acids With POAG.Investigative ophthalmology & visual science · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Chronic Inflammation in Obesity and Cancer Cachexia.Journal of clinical medicine · 2022
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Esther M M OoiMetabolic Research Centre, School of Medicine and Pharmacology, University of Western Australia, Perth, 6000, Western Australia, Australia. esther.ooi@uwa.edu.au.
Gerald F WattsMetabolic Research Centre, School of Medicine and Pharmacology, University of Western Australia, Perth, 6000, Western Australia, Australia. gerald.watts@uwa.edu.au.
Theodore W K NgMetabolic Research Centre, School of Medicine and Pharmacology, University of Western Australia, Perth, 6000, Western Australia, Australia. theodorewai.ng@uwa.edu.au.
P Hugh R BarrettMetabolic Research Centre, School of Medicine and Pharmacology, University of Western Australia, Perth, 6000, Western Australia, Australia. Hugh.Barrett@uwa.edu.au.
University of Western Australia · AURoyal Perth Hospital · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dyslipidemia is a major risk factor for cardiovascular disease (CVD). Dietary fatty-acid composition regulates lipids and lipoprotein metabolism and may confer CVD benefit. This review updates understanding of the effect of dietary fatty-acids on human lipoprotein metabolism. In elderly participants with hyperlipidemia, high n-3 polyunsaturated fatty-acids (PUFA) consumption diminished hepatic triglyceride-rich lipoprotein (TRL) secretion and enhanced TRL to low-density lipoprotein (LDL) conversion. n-3 PUFA also decreased TRL-apoB-48 concentration by decreasing TRL-apoB-48 secretion. High n-6 PUFA intake decreased very low-density lipoprotein (VLDL) cholesterol and triglyceride concentrations by up-regulating VLDL lipolysis and uptake. In a study of healthy subjects, the intake of saturated fatty-acids with increased palmitic acid at the sn-2 position was associated with decreased postprandial lipemia. Low medium-chain triglyceride may not appreciably alter TRL metabolism. Replacing carbohydrate with monounsaturated fatty-acids increased TRL catabolism. Trans-fatty-acid decreased LDL and enhanced high-density lipoprotein catabolism. Interactions between APOE genotype and n-3 PUFA in regulating lipid responses were also described. The major advances in understanding the effect of dietary fatty-acids on lipoprotein metabolism has centered on n-3 PUFA. This knowledge emphasizes the importance of regulating lipoprotein metabolism as a mode to improve plasma lipids and potentially CVD risk. Additional studies are required to better characterize the cardiometabolic effects of other dietary fatty-acids.

Indexed as

Apolipoproteins ECardiovascular DiseasesCholesterol, HDLCholesterol, VLDLDyslipidemiasFatty AcidsFatty Acids, MonounsaturatedFatty Acids, Omega-3Fatty Acids, Omega-6HumansLipid MetabolismRandomized Controlled Trials as TopicRisk FactorsTriglyceridesApolipoproteins ECholesterol, HDLCholesterol, VLDLFatty AcidsFatty Acids, MonounsaturatedFatty Acids, Omega-3Fatty Acids, Omega-6Triglyceridescardiovascular diseasedietary fatty acidsdyslipidemialipoprotein metabolism

Identifiers

PMID26043038
PMCPMC4488792
OpenAlexW2110726673

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.